Cargando…

Transition care in inflammatory bowel disease: A needs assessment survey of Quebec gastroenterologists and allied nurses

AIM: To determine the tools needed and problems encountered during the transition of inflammatory bowel disease (IBD) patients from pediatric to adult gastroenterologists (GIs) in Québec, Canada. METHODS: We conducted a needs assessment survey of Quebec health care professionals (HCPs). The survey w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Strohl, Matthew, Zhang, Xun, Lévesque, Dominique, Bessissow, Talat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547377/ https://www.ncbi.nlm.nih.gov/pubmed/28828197 http://dx.doi.org/10.4292/wjgpt.v8.i3.186

Ejemplares similares

Attitudes and Knowledge of Australian Gastroenterologists Around the Use of Medicinal Cannabis for Inflammatory Bowel Disease
por: Benson, Melissa J, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel Diseases
por: Kablawi, Dana, et al.
Publicado: (2023)

Quality of care in inflammatory bowel diseases: What is the best way to better outcomes?
por: Strohl, Matthew, et al.
Publicado: (2018)

A cross-sectional survey of Saudi gastroenterologists: Transition strategies for adolescents with inflammatory bowel disease
por: Al-Jahdali, Elaf, et al.
Publicado: (2017)

Benefits of implementing a rapid access clinic in a high-volume inflammatory bowel disease center: Access, resource utilization and outcomes
por: Nene, Sofia, et al.
Publicado: (2020)

Inflammatory bowel disease patient profiles are related to specific information needs: A nationwide survey
por: Daher, Saleh, et al.
Publicado: (2019)

Increased Prevalence of Myocardial Infarction and Stable Stroke Proportions in Patients with Inflammatory Bowel Diseases in Quebec in 1996–2015
por: Golovics, Petra Anna, et al.
Publicado: (2022)

Methotrexate in inflammatory bowel disease: A primer for gastroenterologists
por: AlAmeel, Turki, et al.
Publicado: (2022)

Management of inflammatory bowel disease with Clostridium difficile infection
por: D’Aoust, Julie, et al.
Publicado: (2017)

Perspectives on endoscopic surveillance of dysplasia in inflammatory bowel disease: a survey of academic gastroenterologists
por: Gallinger, Zane R., et al.
Publicado: (2017)

Transitions of care across hospital settings in patients with inflammatory bowel disease
por: Warren, Leigh R, et al.
Publicado: (2019)

Knowledge and Interdisciplinary Communication of Gastroenterologists and Dentists in the Netherlands About Gastrointestinal Diseases With Oral Manifestations
por: Tan, Christopher X W, et al.
Publicado: (2022)

Knowledge and attitudes towards the use of histological assessments in ulcerative colitis by gastroenterologists vs pathologists
por: Pudipeddi, Aviv, et al.
Publicado: (2023)

Variations in the medical treatment of inflammatory bowel disease among gastroenterologists
por: Singh, Shailendra, et al.
Publicado: (2018)

The Emerging Adult with Inflammatory Bowel Disease: Challenges and Recommendations for the Adult Gastroenterologist
por: Trivedi, Itishree, et al.
Publicado: (2015)

Gastroenterologists’ Views of Shared Decision Making for Patients with Inflammatory Bowel Disease
por: Siegel, Corey A., et al.
Publicado: (2015)

Variation in Inflammatory Bowel Disease Care among Saudi Pediatric Gastroenterologists
por: Al-Sarkhy, Ahmed A.
Publicado: (2017)

Disease monitoring strategies in inflammatory bowel diseases: What do we mean by “tight control”?
por: Gonczi, Lorant, et al.
Publicado: (2019)

The Optimal Management of Inflammatory Bowel Disease in Patients with Cancer
por: Wetwittayakhlang, Panu, et al.
Publicado: (2023)

Impact of adalimumab on disease burden in moderate-to-severe ulcerative colitis patients: The one-year, real-world UCanADA study
por: Bessissow, Talat, et al.
Publicado: (2022)

Transition clinic attendance is associated with improved beliefs and attitudes toward medicine in patients with inflammatory bowel disease
por: Fu, Nancy, et al.
Publicado: (2017)

Elderly patients with inflammatory bowel disease: Updated review of the therapeutic landscape
por: LeBlanc, Jean-Frédéric, et al.
Publicado: (2019)

Analysis of an IncR Plasmid Carrying bla(NDM-1) Linked to an Azithromycin Resistance Region in Enterobacter hormaechei Involved in an Outbreak in Quebec
por: Doualla-Bell, Florence, et al.
Publicado: (2021)

Isolated Small Bowel Amyloidosis
por: Ghaith, Jenan, et al.
Publicado: (2021)

Barriers to Psychosocial Support and Quality of Life for Patients With Inflammatory Bowel Disease: A Survey Study
por: Lawrence, Rebecca, et al.
Publicado: (2020)

Insufficient Knowledge of Korean Gastroenterologists Regarding the Vaccination of Patients with Inflammatory Bowel Disease
por: Jung, Yoon Suk, et al.
Publicado: (2014)

Positioning of old and new biologicals and small molecules in the treatment of inflammatory bowel diseases
por: Reinglas, Jason, et al.
Publicado: (2018)

Medicinal Cannabis for Inflammatory Bowel Disease: A Survey of Perspectives, Experiences, and Current Use in Australian Patients
por: Benson, Melissa J, et al.
Publicado: (2020)

Questionnaire Survey for Inflammatory Bowel Disease Patients in Japan; A Web-Based Japan, Crohn’s Disease, Ulcerative Colitis, Patients Survey
por: Matsumoto, Takayuki, et al.
Publicado: (2023)

Fecal Incontinence in Inflammatory Bowel Disease
por: Kamal, Natasha, et al.
Publicado: (2021)

A Missing Piece of the Puzzle: Patient and Provider Perspectives on Pain Management Needs and Opioid Prescribing in Inflammatory Bowel Disease Care
por: Balbale, Salva N, et al.
Publicado: (2022)

Influence of Pharmaceutical Direct-to-Consumer Advertisement on Medical Treatment of Inflammatory Bowel Disease—An Outpatient Survey-Based Study
por: Schuster, Isaiah P, et al.
Publicado: (2020)

Very Early-Onset Inflammatory Bowel Disease: A Challenging Field for Pediatric Gastroenterologists
por: Arai, Katsuhiro
Publicado: (2020)

Gastroenterologists Adherence to Tumor Necrosis Factor Antagonist Combination Therapy in Inflammatory Bowel Disease
por: Abdullah, Israa, et al.
Publicado: (2021)

A Patient-Prioritized Agenda for Information Needs During the COVID-19 Pandemic: A Qualitative Study of Patients With Inflammatory Bowel Disease
por: Long, Millie D, et al.
Publicado: (2021)

Therapeutic drug monitoring in inflammatory bowel disease: The dawn of reactive monitoring
por: Albader, Farah, et al.
Publicado: (2021)

Hereditary angioedema: what the gastroenterologist needs to know
por: Ali, M Aamir, et al.
Publicado: (2014)

Checkpoint inhibitors: What gastroenterologists need to know
por: Ahmed, Monjur
Publicado: (2018)

Mpox: What Practicing Gastroenterologists Need to Know
por: Sultan, Shahnaz, et al.
Publicado: (2023)

Strongyloidiasis: what every gastroenterologist needs to know
por: Yeung, Sabrina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2qsc8lr3gshd9hoecdfav64qod